Skip to main content
OpenTrials

Clinical trial condition

Metastatic Melanoma

Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.

228 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Melanoma trial results

Completed

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

NCT02678741

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • University of Alabama Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • John Wayne Cancer Institute/Providence Saint John's Health Center Santa Monica, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
View Trial Details
Completed

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

NCT03123783

Conditions
Cancer, Lung Diseases, Lung Neoplasms, +18 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Hem-Onc Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 23 locations
View Trial Details
Completed

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

NCT02304458

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 25 locations
View Trial Details
Completed

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

NCT03679767

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Fresno, California, United States
  • California Cancer Associates for Research and Excellence Fresno, California, United States
  • California Cancer Associates for Research and Excellence, Inc. San Marcos, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
View all 52 locations
View Trial Details

Related conditions